openPR Logo
Press release

Peptic Ulcers Market to Grow at a Healthy Growth Rate During the Forecast Period (2019-32) - Asserts DelveInsight

04-21-2022 09:13 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Peptic Ulcers Market

Peptic Ulcers Market

DelveInsight's "Peptic Ulcers Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Peptic Ulcers Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Peptic Ulcers market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Peptic Ulcers: An Overview
Peptic ulcer disease is a condition in which painful sores or ulcers develop in the lining of the stomach or the first part of the small intestine (the duodenum). Normally, a thick layer of mucus protects the stomach lining from the effect of its digestive juices. But many things can reduce this protective layer, allowing stomach acid to damage the tissue.

The most common cause of ulcers is an infection of the stomach by bacteria called Helicobacter pylori (H pylori). Most people with peptic ulcers have these bacteria living in their digestive tract. Yet, many people who have these bacteria in their stomach do not develop an ulcer. Additionally, it is observed that people of any age who take NSAIDs every day or multiple times per week are more likely to develop a peptic ulcer than people who do not take them regularly.

Peptic Ulcers Market Key Facts
1. H. pylori causes almost all peptic ulcers, approximately 80 percent of stomach ulcers, and more than 90 percent of duodenal ulcers.
2. As per the study by Hooi et al (2017), the prevalence of Helicobacter pylori infection declines in the United States and Japan.
3. According to a study conducted Morilla et al (2019), over the past years, the prevalence of H. pylori infection in Spain declined gradually.

Find a sample copy of the Peptic Ulcers Market report at:
https://www.delveinsight.com/sample-request/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Peptic Ulcers Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Peptic Ulcers market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Peptic Ulcers market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Peptic Ulcers Epidemiology
The epidemiology section covers detailed insights into the historical and current Peptic Ulcers patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Peptic Ulcers Epidemiology Segmentation
1. Total Prevalent Cases of Peptic Ulcer
2. Type-specific Cases of Peptic Ulcer
3. Total Diagnosed and Treatable Cases of Peptic Ulcer

Explore more about the Peptic Ulcers Epidemiology @
https://www.delveinsight.com/report-store/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Peptic Ulcers Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peptic Ulcers market or expected to get launched in the market during the study period. The analysis covers Peptic Ulcers market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Peptic Ulcers Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for a sample report to understand more about the Peptic Ulcers pipeline development activities @
https://www.delveinsight.com/report-store/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Peptic Ulcers Therapeutics Assessment
Peptic Ulcers Treatment options include empiric antisecretory therapy, empiric triple therapy for H pylori infection, endoscopy followed by appropriate therapy based on findings, and H pylori serology followed by triple therapy for patients who are infected. Breath testing for active H pylori infection may be used.

Currently, there are approx. 8+ key companies which are developing the therapies for Peptic ulcers. The companies which have their Peptic Ulcer drug candidates in the most advanced stage, i.e. phase III include, Daewoong Pharmaceutical.

Some of the key companies in the Peptic Ulcers Market include Daewoong Pharmaceutical, HK inno.N Corporation, PharmaKing, Recce Pharmaceuticals, Sequella Inc, Shandong Luoxin Pharmaceutical, RaQualia Pharma, Sihuan Pharmaceutical Holdings Group, Sinil Pharmaceutical, and several others.

The key therapies in the Peptic Ulcers Therapeutics Market include Fexuprazan, KFP-H008, and many others.

Learn more about the emerging therapies & key companies in the Peptic Ulcers Therapeutics Market @ https://www.delveinsight.com/report-store/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Peptic Ulcers Report Key Insights
1. Peptic Ulcers Patient Population
2. Peptic Ulcers Market Size and Trends
3. Key Cross Competition in the Peptic Ulcers Market
4. Peptic Ulcers Market Dynamics (Key Drivers and Barriers)
5. Peptic Ulcers Market Opportunities
6. Peptic Ulcers Therapeutic Approaches
7. Peptic Ulcers Pipeline Analysis
8. Peptic Ulcers Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Peptic Ulcers Market

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Peptic Ulcers Competitive Intelligence Analysis
4. Peptic Ulcers Market Overview at a Glance
5. Peptic Ulcers Disease Background and Overview
6. Peptic Ulcers Patient Journey
7. Peptic Ulcers Epidemiology and Patient Population
8. Peptic Ulcers Treatment Algorithm, Current Treatment, and Medical Practices
9. Peptic Ulcers Unmet Needs
10. Key Endpoints of Peptic Ulcers Treatment
11. Peptic Ulcers Marketed Products
12. Peptic Ulcers Emerging Therapies
13. Peptic Ulcers Seven Major Market Analysis
14. Attribute Analysis
15. Peptic Ulcers Market Outlook (7 major markets)
16. Peptic Ulcers Access and Reimbursement Overview
17. KOL Views on the Peptic Ulcers Market.
18. Peptic Ulcers Market Drivers
19. Peptic Ulcers Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Peptic Ulcers Market report here:
https://www.delveinsight.com/sample-request/peptic-ulcers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptic Ulcers Market to Grow at a Healthy Growth Rate During the Forecast Period (2019-32) - Asserts DelveInsight here

News-ID: 2607895 • Views:

More Releases from DelveInsight Business Research

Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market. As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates. The Vitiligo Pipeline report offers extensive commercial and clinical
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Myelodysplastic Syndrome Pipeline Report • DelveInsight's Myelodysplastic Syndrome
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape. The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market. The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment

All 5 Releases


More Releases for Peptic

Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,
Peptic Ulcer Market New Product Development & Latest Trends
Introduction Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper portion of the small intestine. They are primarily caused by Helicobacter pylori (H. pylori) infection, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, alcohol consumption, and stress-related factors. Symptoms include abdominal pain, bloating, indigestion, and, in severe cases, gastrointestinal bleeding or perforation. Despite improved therapeutic options, peptic ulcers remain a major healthcare concern worldwide
Evolving Market Trends In The Peptic Ulcer Industry: Advancements In Peptic Ulce …
The Peptic Ulcer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Peptic Ulcer Market Size During the Forecast Period? In recent times, there has been a consistent expansion in the peptic ulcer market size. It is projected to escalate from $4.1 billion
Key Influencer in the Peptic Ulcer Market 2025: Obesity Fuels The Expansion Of T …
What Is the Forecasted Market Size and Growth Rate for the Peptic Ulcer Market? The peptic ulcer market has grown steadily in recent years. It will rise from $4.1 billion in 2024 to $4.24 billion in 2025, at a CAGR of 3.5%. This growth is attributed to the rising prevalence of Helicobacter pylori infection, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns, and a focus
Peptic Ulcer Drugs Market - Relief Within Reach: Transforming Treatment for Pept …
Newark, New Castle, USA - new report, titled Peptic Ulcer Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peptic Ulcer Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peptic Ulcer Drugs market. The report offers an overview of
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if